BEVERLY HILLS, Calif., June 10 /PRNewswire/ -- The Center for Radiation Therapy of Beverly Hills, a state-of-the-art cancer treatment center serving cancer patients in the Los Angeles area, has become one of the select facilities in the country to offer its patients the Calypso® System, a prostate cancer treatment tool that enables clinicians to track tumor motion in real-time.

Calypso Medical, a privately held medical device company, has launched the Aim clinical study using the company's GPS for the Body technology for patients receiving radiation therapy for prostate cancer.

Calypso(R) Medical Technologies, Inc. today announced the launch of the Adaptive Workflow Efficiency release, developed to provide connectivity between the Calypso(R) 4D Localization System(TM) and Varian Medical Systems' 4D integrated treatment console (4DITC).

Calypso Medical announces the launch of the first co-developed product for treatment planning system connectivity between the Calypso® 4D Localization System™ and Philips Medical and Varian Medical treatment planning systems.

Calypso Medical and IMPAC Medical Systems, an Elekta company, have identified product collaboration projects which will further enable integration of oncology management systems with the Calypso® 4D Localization System™.